Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
収録刊行物
-
- J Clin Oncol.
-
J Clin Oncol. 17 3767-3675, 1999